Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olgierd Ashuryk"'
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-4 (2021)
Abstract Background Mutations in BRCA1 and BRCA2 are well-established risk factors for breast and ovarian cancer. In Central-Eastern European counties, the founder mutations in the BRCA1 are responsible for a significant proportion of ovarian cancer
Externí odkaz:
https://doaj.org/article/405db68e7b2947ca951d7f43cb9f83ae
Publikováno v:
Gynecological Endocrinology. 30:187-191
The cystic mature teratomas, including dermoid cysts, are one of the most frequently occurring benign ovarian tumors diagnosed in female patients. The process of neoplastic transformation in mature dermoid cysts is applicable only to 1-2% of cases. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faaa3f58e8cac5bbe546f6d8c84f8d48
https://doi.org/10.3109/09513590.2013.860122
https://doi.org/10.3109/09513590.2013.860122
Autor:
Cezary Cybulski, Józef Kładny, Grzegorz Sukiennicki, Pablo Serrano-Fernández, Barbara Górecka-Szyld, Anna Jakubowska, Jakub Lubiński, Katarzyna Jaworska-Bieniek, Magdalena Muszyńska, Tomasz Huzarski, Tadeusz Dębniak, Anna Wiechowska-Kozłowska, Tomasz Grodzki, Jacek Gronwald, Marcin Lener, Tomasz Byrski, Katarzyna Kaczmarek, Aleksandra Tołoczko-Grabarek, Tomasz Gromowski, Katarzyna Durda, Grażyna Wilk, Ewa Jaworowska, Rodney J. Scott, Antoni W. Morawski, Olgierd Ashuryk, Jan Lubinski
Publikováno v:
Contemporary Oncology
Publication is summarization of existing data being results of literature review and our experience on usefulness of selenium as a diagnostic marker selection for control examinations in surveillance and as a marker of patients with high risk of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e757528f87cabd7d9588a57d70e2e93
https://pubmed.ncbi.nlm.nih.gov/25691823
https://pubmed.ncbi.nlm.nih.gov/25691823
Autor:
Marcin, Lener, Katarzyna, Jaworska, Magdalena, Muszyńska, Grzegorz, Sukiennicki, Katarzyna, Durda, Satish, Gupta, Elżbieta, Złowocka-Perłowska, Józef, Kładny, Anna, Wiechowska-Kozłowska, Tomasz, Grodzki, Ewa, Jaworowska, Jakub, Lubiński, Barbara, Górecka-Szyld, Grażyna, Wilk, Mieczysław, Sulikowski, Tomasz, Huzarski, Tomasz, Byrski, Cezary, Cybulski, Jacek, Gronwald, Tadeusz, Dębniak, Olgierd, Ashuryk, Aleksandra, Tołoczko-Grabarek, Anna, Jakubowska, Antoni, Morawski, Jan, Lubiński
Publikováno v:
Polski przeglad chirurgiczny. 84(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cb4d7be4bce30c925e2d9e5107b04c8
https://pubmed.ncbi.nlm.nih.gov/23241574
https://pubmed.ncbi.nlm.nih.gov/23241574
Autor:
Tomasz Byrski, D Zuziak, Rafał Wiśniowski, Dariusz Godlewski, Olgierd Ashuryk, Tomasz Huzarski, Cezary Cybulski, Jakub Lubiński, Paweł Blecharz, E. Marczyk, Jacek Gronwald, Steven A. Narod
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 10, Iss Suppl 3, p A3 (2012)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Material and methods Between December 2006 and August 2011 seventy five women with BRCA1 mutation and diagnosed with breast cancer stage I to III were enrolled. Patients were treated with Cisplatin at dose 75 mg/m2 every three weeks for four cycles.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caeafa06d183dffcfe2e5f48d4b2ceda
http://www.hccpjournal.com/content/10/S3/A3
http://www.hccpjournal.com/content/10/S3/A3
Autor:
Olgierd Ashuryk, D Gackowski, A Jakubowska, Jacek Gronwald, Katarzyna Durda, Tomasz Huzarski, Krzysztof Kąklewski, Tadeusz Dębniak, A Tołłoczko
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 10, Iss Suppl 3, p A10 (2012)
Hereditary Cancer in Clinical Practice, Vol 10, Iss Suppl 3, p A10 (2012)
Vitamins are important in various biochemical and physiological processes and are essential for the normal functioning of our bodies. Several studies suggested the role of vitamins A, E and D in carcinogenesis. The aim of this study was to analyze an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f2c69b49f5d5c8b28f88bd2820f9c1
http://europepmc.org/articles/PMC3395397
http://europepmc.org/articles/PMC3395397
Autor:
Olgierd Ashuryk, Tomasz Huzarski, Jakub Lubiński, D Zuziak, Tomasz Byrski, Paweł Blecharz, Tadeusz Dębniak, Steven A. Narod, Jacek Gronwald, Dariusz Godlewski, Cezary Cybulski, E. Marczyk, Józef Kładny
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 10, Iss Suppl 1, p A4 (2012)
Hereditary Cancer in Clinical Practice, Vol 10, Iss Suppl 1, p A4 (2012)
ted with cisplatin 75 mg/m 2 every three weeks for four cycles, followed by mastectomy and conventional chemotherapy. Eight patients had prior chemotherapy for a previous cancer diagnosis. Three patients received prior chemotherapy for their current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69354fbfe2240b5f17f4e0473b24ae8